funDERMentals

The Dog Can Stay, but the Rash Must Go


 

DISCUSSION
This is a classic presentation of Grover disease, also known as transient acantholytic dermatosis (AD). While not rare, it is seen only occasionally in dermatology practices. When it does walk through the door, it is twice as likely to be seen in a male than in a female patient and less commonly seen in those with darker skin.

AD is easy enough to diagnose clinically, without biopsy, particularly in classic cases such as this one. The distribution and morphology of the rash, as well as the gender and age of the patient, are all typical of this idiopathic condition. The biopsy results, besides being consistent with AD, did serve to rule out other items in the differential (eg, bacterial folliculitis, pemphigus, and acne).

Since AD was first described in 1974 by R.W. Grover, MD, much research has been conducted to flesh out the nature of the disease, its potential causes, and possible treatment. One certainty about so-called transient AD is that most cases are far from transient—in fact, they can last for a year or more. Attempts have been made to connect AD with internal disease (eg, occult malignancy) or even mercury exposure, but these theories have not been corroborated.

Consistent treatment success has also been elusive. Most patients achieve decent relief with the use of topical steroid creams, with or without the addition of anti-inflammatory medications (eg, doxycycline). Other options include isotretinoin and psoralen plus ultraviolet A (PUVA) photochemotherapy. Fortunately, most cases eventually clear up.

TAKE-HOME LEARNING POINTS

  • Grover disease, also known as transient acantholytic dermatosis (AD), usually manifests with an acute eruption of papulovesicular lesions.
  • AD lesions tend to be confined to the chest and are typically pruritic.
  • Clinical diagnosis is usually adequate, although biopsy, which will reveal typical findings of acantholysis, may be necessary to rule out other items in the differential.
  • Treatment with topical steroids, oral doxycycline, and “tincture of time” usually suffices, but resolution may take a year or more.

Pages

Recommended Reading

Start From Scratch
Clinician Reviews
Tape strips useful to identify biomarkers in skin of young children with atopic dermatitis
Clinician Reviews
Short-term statin use linked to risk of skin and soft tissue infections
Clinician Reviews
Adjunctive therapy is among the roles for topical agents in psoriasis
Clinician Reviews
New mechanisms, therapies for acne considered
Clinician Reviews
Acute Palmar and Plantar Rash in a 52-Year-Old Woman
Clinician Reviews
FDA approves minocycline foam for moderate, severe acne
Clinician Reviews
Atopic Dermatitis
Clinician Reviews
No tacrolimus/cancer link in atopic dermatitis in 10-year study
Clinician Reviews
Boy, Is My Face Red!
Clinician Reviews